Dr. Minnie M. Sarwal, United States
The results of the PRISM (prediction of rejection in sensitized patient blood samples) trial with a novel bioassay

Prof. Duska Dragun, Germany
Significant anti-CMV/BKV effect of a modern everolimus-based regimen comparted to standard tacrolimus-MPA regimen in de novo kidney transplant recipients: Athena 12 months data on infections

Dr. Shiong Yew, Malaysia
Mycophenolic acid therapeutic drug monitoring in de novo renal transplant patients and the related outcomes (Video Available)

Dr. Ivan Margeta, Croatia
Evaluation of cell-mediated immune response by QuantiFERON Monitor® assay in kidney transplant recipients (Video Available)

Dr. Mikiko Yoshikawa, Japan
Effect of everolimus on body composition; 1-year after kidney transplantation (Video Available)

Dr. Joseph Kim, Canada
Tacrolimus - optimization of levels in kidney transplant

Prof. Hyeon Joo Jeong, Korea
Concurrent antibody-mediated rejection in post-transplant IgA nephropathy – diagnosis using a stepwise approach of graft morphology

Ms. Aysen Terzi, Turkey
The influence of polyomavirus infected glomerular cells on the development of glomerulopathy and the graft survival